Eradicating neuroblastomas by an RBM39 degrader in combination with anti-GD2 immunotherapy regardless of cancer cell state alterations

Direct links to NCBI, no account and no request form: the whole study as GSE251920_RAW.tar, processed values as the series matrix, the supplementary file directory, and per-sample supplementary files for any of the 18 samples. Raw sequencing reads are also available from ENA.

Also filed as BioProject PRJNA1055918 and SRA study SRP479693. Searching any of these in the dataset finder brings you back here.

The sample list for this study is not cached yet. Press Sort into groups and it will be fetched from NCBI.

+ 18 more — browse all 18 samples with per-sample file links →

• GSE291730 KLF4 promotes a KRT13+ hillock-like state in squamous lung cancer 55 samples
• GSE274229 Evolution of myeloid-mediated immunotherapy resistance in prostate cancer 52 samples
• GSE310025 Intrinsic RB activation induces tumoral and stromal anti-tumor responses that limit triple-negative breast cancer [RNA-Seq] 28 samples
• GSE301111 Dissecting cellular state alterations critical for the synergistic response and therapy resistance of the combined Abemaciclib, Temozolomide, and Radiation in DIPG PDOX models 14 samples
• GSE264145 Inhibition of DUSP18 impairs cholesterol biosynthesis and promotes anti-tumor immunity in colorectal cancer 12 samples
• GSE281472 Targeting CD206+ macrophages disrupts the establishment of a key anti-tumor immune axis 245 samples
• GSE232555 FOXA2/AP-1 drives prostate cancer lineage plasticity 101 samples
• GSE157927 Triptolide Targets Super-Enhancer Networks in Pancreatic Cancer Cells and Cancer Associated Fibroblasts 81 samples

Search all RNA-seq datasets in GEO →